Steven Zelenkofske is joining uniQure to become the company’s chief medical officer. He succeeds Christian Meyer, who had served as uniQure’s chief medical officer since 2013. Zelenkofske will be based in the Lexington, MA, offices of Netherlands-based uniQure. Zelenkofske was most recently an executive overseeing cardiovascular and metabolism therapeutics for AstraZeneca (NYSE: [[ticker:AZN]]). His experience also includes positions at Sanofi-Aventis, Boston Scientific (NYSE: [[ticker:BSX]]), Novartis (NYSE: [[ticker:NVS]]), and Regado Biosciences.